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Depression and anxiety disorders are highly prevalent and relapse-
prone conditions.1-2 Cognitive behavioural therapy (CBT), a well-established 
psychological intervention, has been shown to reduce the longer-term risk of 
depression relapse. For example, average relapse rates following CBT (~30%) 
compare favourably to relapse rates observed after discontinued 
pharmacotherapy which tend to be upwards of 50%.3-4 In spite of the 
effectiveness and durability of CBT for common mental health problems, 
barriers to its dissemination include the cost of delivery and the scarce 
availability of specialists in many countries. In order to overcome such 
barriers, briefer and less costly ‘low intensity’ forms of CBT (LiCBT) have 
been developed to guide people on how they could self-manage and overcome 
their symptoms.5 LiCBT can be delivered by trained coaches or lay helpers, 
using a variety of methods including individual, group-based, telephone-
based or online support. Meta-analyses of controlled trials support the use 
of LiCBT for the treatment of acute depression and anxiety symptoms,
although there is still inconclusive evidence about its longer-term effects.6-7 
Given its short-term duration (typically < 8 sessions), LiCBT does not 
typically allow for intensive relapse prevention work or booster sessions that 
may account for the durability of more intensive CBT interventions.8 For this 
reason, prospective follow-up studies are necessary to establish if the effects 
of LiCBT are as durable as those observed in more conventional CBT 
interventions. This study reports relapse and recurrence rates in a cohort of 
patients who completed LiCBT in routine care, and who were followed-up on 
a monthly basis for up to 2-years post-treatment. 
The West Yorkshire Low Intensity Outcome Watch (WYLOW) was a 
prospective, longitudinal cohort study. The study recruited 439 patients with 
depression and anxiety disorders who completed LiCBT interventions in a 
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stepped care psychological therapy service linked to the Improving Access to 
Psychological Therapies (IAPT) programme in England. LiCBT interventions 
were highly standardised, were delivered by trained psychological wellbeing 
practitioners, and included individual, group and online forms of treatment 
delivery, consistent with clinical guidelines.9 Participants were eligible for 
inclusion if they completed LiCBT with remission of depression and anxiety 
symptoms, established using diagnostic cut-offs on the PHQ-910 and GAD-
711 measures. Participants were contacted once per month by the research 
team, and completed these measures to monitor their symptoms for up to 24 
months. Cases that met criteria for reliable (>5 points increase) and 
clinically significant (above diagnostic cut-off) deterioration of symptoms on 
any of the 2 measures during follow-up were classified as having a risk 
event. Consistent with previous research,1-3 a risk event was considered a 
relapse if it occurred within 12 months after treatment, and a recurrence if it 
occurred after 12 months. We performed a survival analysis using Kaplan-
Meier (KM) curves to model time-to-event in months. KM curves plot the 
probability of survival (remission) over time, while taking account of 
censored (i.e., missing) data points. 
The sample included a majority of white British (94.2%) female 
participants (59.7%) with a mean age of 41.28 (SD = 14.59), who on average 
accessed 7.04 (SD = 1.99) treatment sessions. Mean pre- and post-treatment 
measures were PHQ-9 = 13.60 (SD = 5.41), 3.44 (SD = 2.40); GAD-7 = 13.20 
(SD = 4.38), 3.19 (SD = 2.17). Full details about recruitment, inclusion 
criteria and methods can be found in a preliminary report of 12-month 
outcomes.12 The study was approved by the NHS Health Research Authority 
(Yorkshire and Humber REC; Ref: 12/YH/0095). 
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[Figure 1] 
Overall, 65.8% (95% CI: 59.3 to 72.2) of cases met criteria for a risk 
event within the 2-year follow-up period (34.2% remained in remission at 24 
months). Figure 1 displays KM survival estimates, plotting the proportion of 
cases remaining in remission at each monthly measurement point. The 
figure quantifies cumulative relapse/recurrence rates at 6 (41.7%), 12 
(52.8%), and 18 months (59.4%). The steeper inclination of the curve in the 
left side of the figure indicates that most risk events (77.8%) occurred within 
the first 6 months post-treatment. Thereafter, 90.6% of events were observed 
by 12 months and 96.2% at 18 months. 
These results indicate that 24 month relapse/recurrence rates 
(65.8%) after completing LiCBT are twice as high as those observed in 
controlled trials of high intensity CBT.3-4 The limited durability of LiCBT for 
some patients could be related to structural constraints such as the lower 
number of sessions, or the emphasis on didactic treatment methods. This 
suggests that halving the length and intensity of treatment may also halve 
the durability of effects. The first 6 months after treatment should be 
considered a critical period where the majority (2 out of 3) of relapse-prone 
cases become apparent. Consistent with earlier studies, we have previously 
reported that cases that completed therapy with residual depression 
symptoms (PHQ-9 = 5 to 9) had double the risk of relapse within the first 
year.12  
Some limitations in this study concern cases lost to follow-up, and the 
lack of structured diagnostic interviews to establish if participants met full 
diagnostic criteria for a mental disorder during the follow-up phase. To deal 
with the first challenge, we applied censoring in survival analysis, which is 
The WYLOW Study DOI: 10.1159/000485386 
appropriate to deal with missing data. Regarding the second problem, we 
applied a stringent and conservative operational definition of relapse, based 
on the observation of both statistically reliable and clinically important 
deterioration in well-established depression and anxiety measures.10-11 
On balance, the present results indicate that LiCBT can be an 
effective way to treat the acute symptoms of depression and anxiety 
disorders, although dedicating time and attention to relapse prevention 
strategies3,6 is a clear area for future development. The findings support the 
notion that, for some individuals, problems like depression are experienced 
as long-term and recurrent conditions and therefore self-management 
support should be an important component of psychological care. 
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Figure 1. Survival analysis: Kaplan-Meier curves plotting time-to-event 
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